Markets:

Overview

News

Currencies

International

Treasuries

SAB Biotherapeutics, Inc. - Common Stock (NQ:SABS)

4.040 +0.040 (+1.00%)

Streaming Delayed Price Updated: 4:00 PM EST, Jan 23, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about SAB Biotherapeutics, Inc. - Common Stock

< Previous 1 2 3 4 5 Next >

12 Health Care Stocks Moving In Friday's After-Market Session ↗

October 03, 2025

Via Benzinga

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

September 30, 2025

Via Benzinga

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

September 23, 2025

Via Benzinga

12 Health Care Stocks Moving In Friday's After-Market Session ↗

September 19, 2025

Via Benzinga

Why Is SAB BIO Stock Trading Lower On Tuesday? ↗

January 28, 2025

SAB BIO's SAB-142 Phase 1 trial data supports its safety and pharmacodynamic activity, paving the way for a Phase 2b trial in T1D in 2025.

Via Benzinga

12 Health Care Stocks Moving In Friday's Intraday Session ↗

September 19, 2025

Via Benzinga

Top movers in Friday's session ↗

September 19, 2025

Curious about what's happening in today's session? Check out the latest stock movements and price changes.

Via Chartmill

Which stocks are gapping on Friday? ↗

September 19, 2025

The market is filled with gapping stocks in Friday's session. Let's discover which stocks are showing gap-ups and gap-downs.

Via Chartmill

Which stocks are moving before the opening bell on Wednesday? ↗

September 03, 2025

Wondering what's happening in Wednesday's pre-market session? Find an overview in this article.

Via Chartmill

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

September 03, 2025

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

July 23, 2025

Via Benzinga

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

July 21, 2025

Via Benzinga

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

May 29, 2025

Via Benzinga

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

May 21, 2025

Via Benzinga

Gold Gains 1%; Boeing Shares Rise Following Q4 Results ↗

January 28, 2025

Via Benzinga

Nasdaq Surges More Than 300 Points; Lockheed Martin Shares Dip After Q4 Results ↗

January 28, 2025

Via Benzinga

Dow Gains Over 50 Points; General Motors Posts Upbeat Earnings ↗

January 28, 2025

Via Benzinga

Topics Stocks

12 Health Care Stocks Moving In Friday's After-Market Session ↗

October 18, 2024

Via Benzinga

SABS Stock Earnings: SAB Biotherapeutics Beats EPS for Q2 2024 ↗

August 09, 2024

SABS stock results show that SAB Biotherapeutics beat analyst estimates for earnings per share the second quarter of 2024.

Via InvestorPlace

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

June 20, 2024

Via Benzinga

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

June 19, 2024

Via Benzinga

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

June 18, 2024

Via Benzinga

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

May 23, 2024

Via Benzinga

SABS Stock Earnings: SAB Biotherapeutics Misses EPS for Q1 2024 ↗

May 21, 2024

SABS stock results show that SAB Biotherapeutics missed analyst estimates for earnings per share the first quarter of 2024.

Via InvestorPlace

Why Applied Therapeutics Shares Are Trading Lower By Over 35%? Here Are Other Stocks Moving In Friday's Mid-Day Session ↗

January 05, 2024

Shares of Applied Therapeutics, Inc.

Via Benzinga

Cal-Maine Foods, UniFirst And 3 Stocks To Watch Heading Into Wednesday ↗

January 03, 2024

With U.S. stock futures trading lower this morning on Wednesday, some of the stocks that may grab investor focus today are as follows:

Via Benzinga

VerifyMe And 3 Other Stocks Under $2 Insiders Are Buying ↗

December 01, 2023

The Dow Jones closed higher by more than 500 points on Thursday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders...

Via Benzinga

Topics Stocks

EXCLUSIVE: SAB Biotherapeutics Kickstarts Phase 1 Study For Its Lead Type 1 Diabetes Hopeful In Australia ↗

November 29, 2023

SAB Biotherapeutics Inc (NASDAQ: SABS) announced that the first HUMAN trial participants (Fully HUman anti-thymocyte biologic in a first-in-MAN clinical study) have been dosed in Australia.

Via Benzinga

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

November 16, 2023

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

October 24, 2023

Via Benzinga

< Previous 1 2 3 4 5 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.